Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 762020, 8 pages
http://dx.doi.org/10.1155/2013/762020
Research Article

Effect of Kramecyne on the Inflammatory Response in Lipopolysaccharide-Stimulated Peritoneal Macrophages

Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Calzada del Hueso 1100, Col. Villa Quietud, Coyoacán, 04960 México, DF, Mexico

Received 1 December 2012; Revised 12 February 2013; Accepted 13 February 2013

Academic Editor: Pradeep Visen

Copyright © 2013 E. Sánchez-Miranda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. T. Dung, V. K. Bajpai, J. I. Yoon, and S. C. Kang, “Anti-inflammatory effects of essential oil isolated from the buds of Cleistocalyx operculatus (Roxb.) Merr and Perry,” Food and Chemical Toxicology, vol. 47, no. 2, pp. 449–453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Nathan, “Points of control in inflammation,” Nature, vol. 420, no. 6917, pp. 846–852, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Rankin, “Biological mediators of acute inflammation,” Advanced Critical Care, vol. 15, no. 1, pp. 3–17, 2004. View at Google Scholar
  4. D. J. Stuehr and M. A. Marletta, “Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 22, pp. 7738–7742, 1985. View at Google Scholar · View at Scopus
  5. S. I. Kanno, A. Shouji, A. Tomizawa et al., “Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages,” Life Sciences, vol. 78, no. 7, pp. 673–681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Y. Lee, J. A. Lee, C. S. Seo et al., “Anti-inflammatory activity of Angelica dahurica ethanolic extract on RAW264.7 cells via upregulation of heme oxygenase-1,” Food and Chemical Toxicology, vol. 49, no. 5, pp. 1047–1055, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. L. Davis, E. Martin, I. V. Turko, and F. Murad, “Novel effects of nitric oxide,” Annual Review of Pharmacology and Toxicology, vol. 41, pp. 203–236, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Gautam and S. M. Jachak, “Recent developments in anti-inflammatory natural products,” Medicinal Research Reviews, vol. 29, no. 5, pp. 767–820, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Pérez, E. Sánchez, M. Martínez, M. A. Zavala, and C. Pérez, “Kramecyne—a new anti-inflammatory compound isolated from Krameria cytisoides,” Molecules, vol. 17, pp. 2049–2057, 2012. View at Google Scholar
  10. A. Elmann, S. Mordechay, H. Erlank, A. Telerman, M. Rindner, and R. Ofir, “Anti-Neuroinflammatory effects of the extract of Achillea fragrantissima,” BMC Complementary and Alternative Medicine, vol. 11, p. 98, 2011. View at Google Scholar
  11. K. S. Ahn, E. J. Noh, H. L. Zhao, S. H. Jung, S. S. Kang, and Y. S. Kim, “Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells,” Life Sciences, vol. 76, no. 20, pp. 2315–2328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Ialenti, S. Moncada, and M. Di Rosa, “Modulation of adjuvant arthritis by endogenous nitric oxide,” British Journal of Pharmacology, vol. 110, no. 2, pp. 701–706, 1993. View at Google Scholar · View at Scopus
  13. M. A. Dobrovolskaia and S. N. Vogel, “Toll receptors, CD14, and macrophage activation and deactivation by LPS,” Microbes and Infection, vol. 4, no. 9, pp. 903–914, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. D. O. Adams and T. A. Hamilton, “The cell biology of macrophage activation,” Annual Review of Immunology, vol. 2, pp. 283–318, 1984. View at Google Scholar · View at Scopus
  15. G. L. Larsen and P. M. Henson, “Mediators of inflammation,” Annual Review of Immunology, vol. 1, pp. 335–359, 1983. View at Google Scholar · View at Scopus
  16. T. Lawrence, D. A. Willoughby, and D. W. Gilroy, “Anti-inflammatory lipid mediators and insights into the resolution of inflammation,” Nature Reviews Immunology, vol. 2, no. 10, pp. 787–795, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. T. J. Guzik, R. Korbut, and T. Adamek-Guzik, “Nitric oxide and superoxide in inflammation and immune regulation,” Journal of Physiology and Pharmacology, vol. 54, no. 4, pp. 469–487, 2003. View at Google Scholar · View at Scopus
  18. C. Nathan, “Points of control in inflammation,” Nature, vol. 420, no. 6917, pp. 846–852, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Rankin, “Biological mediators of acute inflammation,” AACN Clinical Issues, vol. 15, no. 1, pp. 3–17, 2004. View at Google Scholar · View at Scopus
  20. K. Kazłowska, T. Hsu, C. C. Hou, W. C. Yang, and G. J. Tsai, “Anti-inflammatory properties of phenolic compounds and crude extract from Porphyra dentata,” Journal of Ethnopharmacology, vol. 128, no. 1, pp. 123–130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. F. M. Michelini, J. A. Ramírez, A. Berra, L. R. Galagovsky, and L. E. Alché, “Anti-herpetic and anti-inflammatory activities of two new synthetic 22,23-dihydroxylated stigmastane derivatives,” Journal of Steroid Biochemistry and Molecular Biology, vol. 111, no. 1-2, pp. 111–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Mueller, S. Hobiger, and A. Jungbauer, “Anti-inflammatory activity of extracts from fruits, herbs and spices,” Food Chemistry, vol. 122, no. 4, pp. 987–996, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Paulino, N. C. Rodrigues, P. C. Pardi et al., “Evaluation of anti-inflammatory effect of synthetic 1,5-bis(4-acetoxy-3-methoxyphenyl)-1,4-pentadien-3-one, HB2,” Bioorganic and Medicinal Chemistry, vol. 17, no. 13, pp. 4290–4295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Prawan, C. L. L. Saw, T. O. Khor et al., “Anti-NF-κB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling,” Chemico-Biological Interactions, vol. 179, no. 2-3, pp. 202–211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Q. Van, B. N. Nayak, M. Reimer, P. J. H. Jones, R. G. Fulcher, and C. B. Rempel, “Anti-inflammatory effect of Inonotus obliquus, Polygala senega L., and Viburnum trilobum in a cell screening assay,” Journal of Ethnopharmacology, vol. 125, no. 3, pp. 487–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Q. Li, L. C. He, and J. Q. Jin, “Atractylenolide I and atractylenolide III inhibit lipopolysaccharide- induced TNF-α and NO production in macrophages,” Phytotherapy Research, vol. 21, no. 4, pp. 347–353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Ponnuchamy and R. A. Khalil, “Cellular mediators of renal vascular dysfunction in hypertension,” American Journal of Physiology, vol. 296, no. 4, pp. R1001–R1018, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. U. Zulkhurnain, I. A. M. Mohamed, I. A. Mohd, F. A. J. Mohd, and M. L. Tan, “Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E2 production induced by lipopolysaccharide in RAW 264.7 macrophage cells,” Journal of Ethnopharmacology, vol. 136, no. 1, pp. 75–82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Ialenti, A. Ianaro, S. Moncada, and M. Di Rosa, “Modulation of acute inflammation by endogenous nitric oxide,” European Journal of Pharmacology, vol. 211, no. 2, pp. 177–182, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Iuvone, R. Carnuccio, and M. Di Rosa, “Modulation of granuloma formation by endogenous nitric oxide,” European Journal of Pharmacology, vol. 265, no. 1-2, pp. 89–92, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Klosterhalfen and R. S. Bhardwaj, “Septic shock,” General Pharmacology, vol. 31, no. 1, pp. 25–32, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. R. M. Clancy and S. B. Abramson, “Nitric oxide: a novel mediator of inflammation,” Proceedings of the Society for Experimental Biology and Medicine, vol. 210, no. 2, pp. 93–101, 1995. View at Google Scholar · View at Scopus
  33. D. Sarkar, P. Saha, S. Gamre et al., “Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-κB pathway,” International Immunopharmacology, vol. 8, no. 9, pp. 1264–1271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Epe, D. Ballmaier, I. Roussyn, K. Briviba, and H. Sies, “DNA damage by peroxynitrite characterized with DNA repair enzymes,” Nucleic Acids Research, vol. 24, no. 21, pp. 4105–4110, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. Md. Nurul Islam, R. Joo Choi, S. Eun Jin et al., “Mechanism of anti-inflammatory activity of umbelliferone 6-carboxylic acid isolated from Angelica decursiva,” Journal of Ethnopharmacology, vol. 144, pp. 175–181, 2012. View at Google Scholar
  36. M. A. Marletta, “Nitric oxide synthase structure and mechanism,” Journal of Biological Chemistry, vol. 268, no. 17, pp. 12231–12234, 1993. View at Google Scholar · View at Scopus
  37. C. Nathan and Q. W. Xie, “Regulation of biosynthesis of nitric oxide,” Journal of Biological Chemistry, vol. 269, no. 19, pp. 13725–13728, 1993. View at Google Scholar · View at Scopus
  38. W. K. Alderton, C. E. Cooper, and R. G. Knowles, “Nitric oxide synthases: structure, function and inhibition,” Biochemical Journal, vol. 357, no. 3, pp. 593–615, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. C. S. Sung and C. S. Wong, “Cellular mechanisms of neuroinflammatory pain: the role of interleukin-1β,” Acta Anaesthesiologica Taiwanica, vol. 45, no. 2, pp. 103–109, 2007. View at Google Scholar · View at Scopus
  40. K. Vuolteenaho, T. Moilanen, R. G. Knowles, and E. Moilanen, “The role of nitric oxide in osteoarthritis,” Scandinavian Journal of Rheumatology, vol. 36, no. 4, pp. 247–258, 2007. View at Google Scholar · View at Scopus
  41. B. G. Harbrecht, M. Di Silvio, A. J. Demetris, R. L. Simmons, and T. R. Billiar, “Tumor necrosis factor-α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia,” Hepatology, vol. 20, no. 4 I, pp. 1055–1060, 1994. View at Google Scholar · View at Scopus
  42. C. Tsatsanis, A. Androulidaki, M. Venihaki, and A. N. Margioris, “Signalling networks regulating cyclooxygenase-2,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 10, pp. 1654–1661, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Aronoff and E. Neilso, “Antipyretics: mechanism of action and clinical use in fever suppression,” American Journal of Medicine, vol. 327, pp. 749–754, 2001. View at Google Scholar
  44. J. L. Masferrer, B. S. Zweifel, P. T. Manning et al., “Selective inhibition of inducible cyclooxygenase 2 in vivo is anti inflammatory and nonulcerogenic,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 8, pp. 3228–3232, 1994. View at Google Scholar · View at Scopus
  45. Q. Van, B. N. Nayak, M. Reimer, P. J. H. Jones, R. G. Fulcher, and C. B. Rempel, “Anti-inflammatory effect of Inonotus obliquus, Polygala senega L., and Viburnum trilobum in a cell screening assay,” Journal of Ethnopharmacology, vol. 125, no. 3, pp. 487–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Clàiria, “Cyclooxygenase-2 biology,” Current Pharmaceutical Design, vol. 9, no. 27, pp. 2177–2190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. M. C. Allison, A. G. Howatson, C. J. Torrance, F. D. Lee, and R. I. Russell, “Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs,” The New England Journal of Medicine, vol. 327, no. 11, pp. 749–754, 1992. View at Google Scholar · View at Scopus
  48. C. E. Eberhart and R. N. Dubois, “Eicosanoids and the gastrointestinal tract,” Gastroenterology, vol. 109, no. 1, pp. 285–301, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Holtmann and K. Resch, “Cytokine,” Die Naturwissenchaften, vol. 82, pp. 178–187, 1995. View at Google Scholar
  50. B. Beutler and A. Cerami, “The biology of cachectin/TNF-α primary mediator of the host response,” Annual Review of Immunology, vol. 7, pp. 625–655, 1989. View at Google Scholar · View at Scopus
  51. Y. C. Hseu, F. Y. Wu, J. J. Wu et al., “Anti-inflammatory potential of Antrodia Camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-κB pathway,” International Immunopharmacology, vol. 5, no. 13-14, pp. 1914–1925, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Garlanda, D. Di Liberto, A. Vecchi et al., “Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling,” Journal of Immunology, vol. 179, no. 5, pp. 3119–3125, 2007. View at Google Scholar · View at Scopus
  53. S. J. Park, J. A. Jung, S. J. Lee, and H. M. Kim, “The phosphatidylinositol 3 kinase inhibitor, LY294002, block TNF-α and IL-6 production in activated RAW-264. 7 cells,” Bulletin of Life Science and Biotechnology, vol. 6, pp. 3–17, 1999. View at Google Scholar
  54. Q. Van, B. N. Nayak, M. Reimer, P. J. H. Jones, R. G. Fulcher, and C. B. Rempel, “Anti-inflammatory effect of Inonotus obliquus, Polygala senega L., and Viburnum trilobum in a cell screening assay,” Journal of Ethnopharmacology, vol. 125, no. 3, pp. 487–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. S. Marcus, S. L. Karackattu, M. A. Fleegal, and C. Sumners, “Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-κB,” GLIA, vol. 41, no. 2, pp. 152–160, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. L. I. Schrader, D. A. Kinzenbaw, A. W. Johnson, F. M. Faraci, and S. P. Didion, “IL-6 deficiency protects against angiotensin II-induced endothelial dysfunction and hypertrophy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2576–2581, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. P. J. Barnes and M. Karin, “Nuclear factor-κB—a pivotal transcription factor in chronic inflammatory diseases,” The New England Journal of Medicine, vol. 336, no. 15, pp. 1066–1071, 1997. View at Publisher · View at Google Scholar · View at Scopus